Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × toripalimab × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 4 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Small Cell Lung Carcinoma 2 Recurrence 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Head and Neck Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Stomach Neoplasms 1 Solid Tumor 1 Solid Cancer 1 Sarcoma 1 SCLC, Extensive Stage 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 Mouth Neoplasms 1 Melanoma 1 Locally Advanced or Metastatic GC and GCJ Adenocarcinoma 1

Interventions

atezolizumab 3 Etoposide 2 Cisplatin 2 zimberelimab 1 tivozanib 1 durvalumab 1 cabozantinib 1 belinostat 1 Temozolomide 1 Standard of Care 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡